ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Inflammasome"

  • Abstract Number: 2518 • ACR Convergence 2024

    Behçet’s Disease Immune Landscape Exhibits a Universal NF-kB-mediated Hyperactivation Pattern with Cell-specific TNFAIP3 Responses and a Superimposed IFN-regulated Endotype

    Yesim Ozguler1, Olivier Manches2, Didar Ucar3, Ziyan Lin2, Alireza Khodadadi-Jamayran2, Aristotelis Tsirigos2, Gulen Hatemi1 and Johannes Nowatzky4, 1Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, 2NYU Grossman School of Medicine, New York, NY, 3Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Ophthalmology, Istanbul, Turkey, 4New York University Grossman School of Medicine, New York, NY

    Background/Purpose: The immune landscape of Behçet’s disease (BD) remains ill-defined, lacking a unifying picture, precise disease phenotype-endotype correlations, and an understanding of immunity at target…
  • Abstract Number: 0072 • ACR Convergence 2024

    The Association Between Activation of Inflammasome and HLA-B27 in Dendritic Cells of Patients with Axial Spondyloarthritis

    Jina Yeo1, Min-Gang Kim2, Hye Eun Lee3, Yeonsoo Yang2, Mi Ryoung Seo1, Hyo-Jin Choi1, Eun Young Lee4, Dae Ho Lee3 and Han Joo Baek5, 1Division of Rheumatology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea, 2Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea, 3Division of Endocrinology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea, 43Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea, 5Division of Rheumatology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Inchon, South Africa

    Background/Purpose: Axial spondyloarthritis (axSpA) exhibits a predominant involvement of the innate immune system, marked by abnormal functions of innate immune cell such as dendritic cells…
  • Abstract Number: 0917 • ACR Convergence 2024

    Role of Mutual Information Profile Shifts in Assessing the Pathogenicity of Mutations on Protein Functions: The Case of Pyrin Mutations in Familial Mediterranean Fever

    Aysima Hacisuleyman1, Ahmet Gul2 and Burak Erman3, 1Department of Computational Biology, University of Lausanne, Lausanne, Switzerland, 2Division of Rheumatology, Department of Internal Medicine, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, Istanbul, Turkey, 33Chemical and Biological Engineering, Koc University, Istanbul, Turkey

    Background/Purpose: Predicting the pathogenicity of amino acid substitutions is crucial for understanding the functional consequences of genetic variations. Several computational methods frequently used so far…
  • Abstract Number: 0920 • ACR Convergence 2024

    TGF-β Activated Kinase 1 Inhibition by Pentagalloyl Glucose Inhibits NLRP3 Inflammasome Formation and Ameliorates MSU-Induced Inflammation

    Paul Panipinto1 and Salahuddin Ahmed2, 1Washington State University College of Pharmaceutical Science and Molecular Medicine, Spokane, WA, 2Washington State University, Spokane, WA

    Background/Purpose: Monosodium urate (MSU)-induced inflammation is caused by the deposition of MSU crystals in the joints and periarticular tissues under conditions of hyperuricemia. These deposits…
  • Abstract Number: 0058 • ACR Convergence 2023

    Macrophage Extracellular Traps Induced by Monosodium Urate or Calcium Pyrophosphate Crystals Form Independently of NLRP3 Inflammasome Activation

    Douglas Daoudlarian1, André Tiaden2, Stavros Giaglis3, Ulrich Walker4, Petr Broz5, Tobias Maningold6 and Diego Kyburz1, 1University Hospital Basel, Basel, Switzerland, 2Laboratory for Experimental Rheumatology, Department of Biomedicine, University of Basel, Basel, Switzerland, 3University of Basel/University Hospital of Basel, Basel, Switzerland, 4Basel University Hospital, Basel, Switzerland, 5University of Lausanne, Lausanne, Switzerland, 6Department of Rheumatology, University Hospital Bern (Inselspital), University Bern, Bern, Switzerland

    Background/Purpose: Monosodium urate (MSU) and calcium pyrophosphate (CPP) crystals are potent inducers of inflammation by activation of the inflammasome in neutrophils phagocytosing the crystals and…
  • Abstract Number: 1106 • ACR Convergence 2023

    Monosodium Urate and Calcium Pyrophosphate Crystal-induced Inflammation Relies on Cell Volume Regulation and LRRC8/VRAC Channel Activation

    Twinu Wilson Chirayath1, mete kayatekin2, Isabelle Rubera3, Nghia Pham4, FREDERIC LIOTE4, Pascal Richette5, Vincent COMPAN6, François Rassendren7, Christophe Duranton3 and Hang Korng EA4, 1INSERM, Paris, France, 2CNRS-UMR7370, Nice, France, 3CNRS-UMR 7370, Nice, France, 4INSERM-BIOSCAR, Paris, France, 5Lariboisière Hospital, Paris, France, 6CNRS-IGF, Montpellier, France, 7CNRS UMR 5203, Montpellier, France

    Background/Purpose: Monosodium urate (MSU) and calcium pyrophosphate (CPP) crystals are responsible for interleukin (IL)-1β dependent acute arthritis. The release of mature IL-1β is dependent on…
  • Abstract Number: 2058 • ACR Convergence 2023

    IL-1 Blocking Treatment Slows the Progression of Sensorineural Hearing Loss in Patients with NOMID

    Sara Alehashemi1, Ana M. Ortega-Villa2, Megha Garg3, Katherine Myint-Hpu4, Kim Johnson5, FARZANA BHUYAN6, Kelly King7, Chris Zalewski7, Danielle Fink8, Douglas B. Kuhns8, John Butman9, Carmen Brewer7, H. Jeffrey Kim7, Dean Follmann2 and Raphaela Goldbach-Mansky10, 1NIH/NIAID/TADS, Clarksville, MD, 2Biostatistics Research Branch, Division of Clinical Research, NIH, Bethesda, MD, 3Rochester Regional Health, Pittsford, NY, 4NIAID, NIH, Bethesda, MD, 5NIH, NIAID, Bethesda, MD, 6National Institutes of Health, Bethesda, MD, 7National Institute on Deafness and Other Communication Disorders, NIH, Bethesda, MD, 8Frederick National Laboratory for Cancer Research, Bethesda, MD, 9Clinical Center, NIH, Bethesda, MD, 10NIH/NIAID, Potomac, MD

    Background/Purpose: NOMID is a severe form of cryopyrin-associated periodic syndrome characterized by systemic inflammation and CNS manifestations, including sensorineural hearing loss. IL-1 blocking agents, Anakinra…
  • Abstract Number: PP11 • ACR Convergence 2023

    We Suffered For Decades, But Then She Was Born

    Ian Stedman1 and Barbara Stedman2, 1Canadian Autoinflammatory Network, Vaughan, ON, Canada, 2Canadian Autoinflammatory Network, Turkey Point, ON, Canada

    Background/Purpose: I was born in 1981; my mother in 1949; and my grandmother in 1926. Our story runs at least four generations deep, that we…
  • Abstract Number: 032 • 2023 Pediatric Rheumatology Symposium

    From Bedside to Bench and Back: Discovery of a Novel Missense Variant in NLRP3 Causing Atypical Cryopyrin-Associated Periodic Syndromes with Hearing Loss as the Primary Presentation, Responsive to Anti-IL1 Therapy

    Merav Birk-Bachar1, Hadar Cohen2, Yoel Levinsky3, rotem tal4, Gil Amarilyo5, Meirav Sokolov6, Efrat Sofrin-Drucker7, Naama Orenstein7, Gabriel Lidzbarsky7, Liora Kornreich8, Eyal Raveh6, Nesya Kropach-Gilad7, Motti Gerlic2 and Liora Harel9, 1Pediatric Rheumatology Unit, Schneider Children's Medical Center of Israel, Petach Tikva, Israel, 2Sackler Faculty of Medicine, Immunology Department, Tel Aviv University, Tel Aviv, Israel, 3Schneider Children's Medical Center of Israel, Tel Aviv University, Petach Tikva, Israel, 4Schneider Children's Medical Center of Israel, Petach Tikva, Israel, 5Schneider Children's Medical Center of Israel, Petach Tikva, Israel, 6Pediatric Ear Nose and Throat Unit Unit, Schneider Children's Medical Center of Israel, Petach Tikva, Israel, 7Recanati Genetic Institute, Rabin Medical Center-Beilinson Hospital, Petach Tikva, Israel, 8Pediatric Imaging Unit, Schneider Children's Medical Center of Israel, Petach Tikva, Israel, 9Scheiders Children Medical Center of Israel, Petah-Tiqva, Israel

    Background/Purpose: Cryopyrin-associated periodic syndromes (CAPS) are a spectrum of rare autoinflammatory diseases caused by gain-of-function mutations inthe NLRP3 gene. These mutations cause inflammasome hyperactivity and…
  • Abstract Number: 0025 • ACR Convergence 2022

    Wnt Pathway/Innate Immunity Equilibrium in OA Articular Cells

    Eloi Franco-Trepat1, Ana Alonso Pérez1, María Guillán-Fresco2, Miriam López Fagúndez1, Andrés Pazos-Pérez3, Antia Crespo Golmar4, María Piñeiro-Ramil5, Ana Lois Iglesias6, Alberto Jorge-Mora1 and Rodolfo Gomez1, 1MSP Group - Institute IDIS - CHUS - SERGAS, Santiago de Compostela, Spain, 2MSP Group - Institute IDIS - CHUS - SERGAS, Catoira, Spain, 3MSP Group - Institute IDIS - CHUS - SERGAS, Pontevedra, Spain, 4MSP Group - Institute IDIS - CHUS - SERGAS, León, Spain, 5MSP Group - Institute IDIS - CHUAC - SERGA, A Coruña, Spain, 6MSP Group - Institute IDIS - CHUAC - SERGAS, A Coruña, Spain

    Background/Purpose: The progressive degradation of osteoarthritis (OA) cartilage has been associated with articular innate immune responses (IIR) mediated by the Toll-like receptor 4 (TLR4). Additionally,…
  • Abstract Number: 0148 • ACR Convergence 2022

    Dysferlin Associated Autoinflammatory Disease Causing Systemic Inflammation and Sterile Lung Abcesses Through Impaired Efferocytosis

    Farzana Bhuyan1, Adriana Almeida de Jesus2, Clinton Bradfield3, Mohammad Arif Rahman4, Andre Rastegar3, sundar ganesan3, Sachin Gaurav3, Sara Alehashemi3, Ronit Herzog5, Steven Holland3, Deborah Consilini6, Iain Fraser3 and Raphaela Goldbach-Mansky7, 1National Institutes of Health, Bethesda, MD, 2NIAID, NIH, Silver Spring, MD, 3NIAID, Bethesda, MD, 4NCI, Bethesda, MD, 5Langone Medical Center, New York, NY, 6Nemours Children's Hospital-Delaware, Wilmington, DE, 7NIAID, NIH, Rockville

    Background/Purpose: Using whole exome sequencing (WES), we identified a de novo mutation in DYSF encoding dysferlin in 2 unrelated patients with systemic inflammation and sterile…
  • Abstract Number: 0557 • ACR Convergence 2022

    VEXAS Syndrome Is Characterized by Blood and Tissues Inflammasome Pathway Activation and Monocyte Dysregulation

    Benjamin Terrier1, Celine Posseme2, Marie Temple3, Aurélien Corneau4, Francesco Carbone5, Eugénie Duroyon3, camille Gobeaux3, Estibaliz Lazaro6, Roderau Outh7, Guillaume Le Guenno8, Francois Lifermann9, Marie Berleur10, Thierry Weitten11, Vivien Guillotin12, Cédric Lenormand13, Hang-Korng Ea14, Mickael Ménager5, Darragh Duffy2 and Olivier Kosmider3, 1National Referral Center for Rare Systemic Autoimmune Diseases, Cochin Hospital, Paris, France, 2Institut Pasteur, Paris, France, 3Cochin Hospital, Paris, France, 4Pitié Salpêtrière Hospital, Paris, France, 5Institut Imagine, Paris, France, 6Bordeaux Hospital University, Bordeaux, France, 7CH, Perpignan, France, 8CHU, Clermont-Ferrand, France, 9Dax Hospital, Dax, France, 10CH, Versailles, France, 11CHIGAS, Gap, France, 12CHU Bordeaux, Bordeaux, France, 13CHRU, Strasbourg, France, 14Lariboisière Hospital, Paris, France

    Background/Purpose: Acquired mutations in the UBA1 gene, occurring in myeloid cells and resulting in expression of a catalytically impaired isoform of the enzyme E1, were…
  • Abstract Number: 0818 • ACR Convergence 2022

    NLRP12-associated Autoinflammatory Disease in Chinese Adult Patients: A Single-center Study

    Junke Miao and Min Shen, Department of Rheumatology, Peking Union Medical College Hospital, Beijing, China

    Background/Purpose: NLRP12-associated autoinflammatory disease (NLRP12-AID) is an autosomal dominant autoinflammatory disorder caused by variants of the NLRP12 gene, which lead to a reduction of the…
  • Abstract Number: 1691 • ACR Convergence 2022

    Pentagalloyl Glucose Inhibits MSU-Induced Inflammation via Transforming Growth Factor-β-Activated Kinase 1 (TAK1)

    Paul Panipinto, Anil Singh, Farheen Sultan Shaikh and Salahuddin Ahmed, Washington State University, Spokane, WA

    Background/Purpose: Gout disease flares occur when primed macrophages interact with and phagocytose monosodium urate crystals (MSU), activating IL-1β via the NLRP3 inflammasome. Abrogation of inflammasome…
  • Abstract Number: 1010 • ACR Convergence 2021

    Proton Pump Inhibitors Suppress IL-1 Mediated Carditis in a Murine Model of Kawasaki Disease

    Paul Tsoukas1, Melissa Kleinau2, Lysa Langevin2, Lily Morikawa3, Trang Duong1, Suzanne Tam4 and Rae Yeung5, 1Hospital for Sick Children, Toronto, ON, Canada, 2University of Toronto, Toronto, ON, Canada, 3The Hospital for Sick Children, Toronto, ON, 4Hospital for Sick Children, Toronto, ON, 5The Hospital for Sick Children, Toronto, ON, Canada

    Background/Purpose: Kawasaki disease (KD), is the leading cause of acquired heart disease in childhood. Up to 20% of patients may develop coronary artery lesions (CAL)…
  • « Previous Page
  • 1
  • 2
  • 3
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology